Journal Editorial Report: The week's best and worst from Kate Odell, Kyle Peterson and Dan Henninger. Photo: Ben Curtis/Allison Robbert/AP/Stefani Reynolds/CNP via ZUMA Wire Indian manufacturers ...

With a state-of-the-art lab and an advisory committee featuring local employers, the biotechnology program launching this fall at Omaha's Metropolitan Community College aims to equip students to enter ...

CARVYKTI ® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $555 million and $1.9 billion for the fourth quarter and full year 2025, respectively Surpassed milestone of more ...

A controversial political appointee at the Food and Drug Administration plans to step down for a second time, and the biotech company at the center of a recent debate that involved him saw its stock ...

The ISC Class 12 Mathematics Exam 2026 was successfully conducted today, March 9, 2026, by the Council for the Indian School Certificate Examinations (CISCE). The examination was held from 2:00 PM to ...

Vertex Pharmaceuticals' current lineup could drive top-line growth well into the 2030s. The company should launch brand-new products that will take over after that. The stock looks like a great pick ...

ISC Class 12 Biology Exam 2026 was conducted on 6 March 2026 from 2:00 PM to 5:00 PM by the Council for the Indian School Certificate Examinations (CISCE). Biology is an important subject for Class 12 ...

In a post-conference reflection, Annie J. Ferris, MD, emphasizes the profound human side of post-stroke research beyond clinical data and innovations. She was deeply moved by a presentation at ISC ...

– Conference call scheduled for February 23, 2026, at 5:30 p.m. ET / 2:30 p.m. PT Vir Biotechnology, Inc. (Nasdaq: VIR), today provided a corporate update and reported financial results for the fourth ...

Redmile Group added 695,000 shares of Immunome last quarter; the estimated trade size was $12.20 million based on average prices for the quarter. The quarter-end position value increased by $64.01 ...

Biotech stock Grail Inc (NASDAQ:GRAL) is taking a nosedive today, brushing off better-than-expected fourth-quarter results after the company's three-year cancer screening trial failed to meet its main ...

Key takeaways from ISC 2026 included positive outcomes in stroke prevention, postthrombectomy care, and the return of neuroprotection. The 2026 International Stroke Conference (ISC), held February 4-6 ...